docetaxel anhydrous has been researched along with cyproterone acetate in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (cyproterone acetate) | Trials (cyproterone acetate) | Recent Studies (post-2010) (cyproterone acetate) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 1,845 | 339 | 261 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | cyproterone acetate (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.225 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.225 | |
| Androgen receptor | Homo sapiens (human) | 0.1408 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.339 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.225 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.225 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.225 | |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.045 | |
| Mu-type opioid receptor | Homo sapiens (human) | 2.183 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buijs, JT; Culig, Z; Grimm, S; Hemmer, DM; Hwang, MS; Kroon, J; Marijt, KA; Masood, M; Meijer, OC; Metselaar, JM; Puhr, M; Storm, G; van der Horst, G; van der Pluijm, G | 1 |
1 other study(ies) available for docetaxel anhydrous and cyproterone acetate
| Article | Year |
|---|---|
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.
Topics: Apoptosis; Cyproterone Acetate; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Male; Mifepristone; Prostatic Neoplasms; Receptors, Glucocorticoid; Taxoids; Tumor Cells, Cultured | 2016 |